SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending strongly as the community anticipates robust annual results, driven by surging defense contracts and civil aerospace recovery, alongside expectations for a significant share buyback program and strategic advancements in Small Modular Reactors.

Hamilton Insurance Group Ltd. is a holding company, which provides insurance and reinsurance services. It operates through the International and Bermuda segments. The International segment comprises of property, specialty, and casualty insurance and reinsurance classes of business originating from the company's London, Dublin, and Hamilton Select operations. The Bermuda segment offers property, specialty, and casualty insurance and reinsurance classes of business originating from Hamilton Re, Bermuda and Hamilton Re US and subsidiaries. The company was founded in 2013 and is headquartered in Hamilton, Bermuda.

Hamilton Insurance Group Ltd. - Ordinary Shares - Class B

Hamilton Insurance Group is gaining attention for its strong financial performance, which includes consistent earnings beats and a recent AM Best rating upgrade, leading many investors to view it as a significantly undervalued insurance play despite ongoing community discussions regarding its leadership's market communication.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending amid resurfacing acquisition rumors, with French publication La Lettre reporting a potential $176-per-share offer from AstraZeneca following earlier Eli Lilly bid speculation. The community is actively discussing the differentiated profile of obefazimod for inflammatory bowel disease and the high buyout premium the company could command.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following FDA approval for BYSANTI (milsaperidone) for schizophrenia and bipolar I disorder, a New Chemical Entity with patent protection until 2044. The community is actively discussing the significant undervaluation, potential for a short squeeze, and strong buyout interest from major pharmaceutical companies seeking to offset patent cliffs and capitalize on Vanda's deep pipeline, including its "mega blockbuster" Tradipitant for GLP-1 induced nausea.

Sensata Technologies Holding Plc is a global industrial technology company, which engages in the development, manufacture, and sale of sensors and sensor-rich solutions, electrical protection components and systems, and other products used in mission-critical systems and applications. The firm operates through the Performance Sensing and Sensing Solutions segments. The Performance Sensing segment serves the automotive and heavy vehicle and off-road (HVOR) industries through the development and manufacture of sensors, high-voltage solutions, and other solutions used in mission-critical systems and applications. The Sensing Solutions segment engages in the industrial and aerospace industries through the development and manufacture of a portfolio of application-specific sensor and electrical protection products used in industrial markets, including the appliance, heating, ventilation, and air conditioning (HVAC), water management, operator controls, charging infrastructure, renewable energy generation, green hydrogen production, and microgrid applications and markets, as well as the aerospace market, including commercial aircraft, defense, and aftermarket markets. The company was founded by Rathbun Willard in 1916 and is headquartered in Attleboro, MA.

Sensata Technologies Holding Plc

Sensata Technologies (ST) is trending after a mixed reaction to its recent Q4 earnings beat, as shares pulled back despite solid results and several analyst price target raises. The community is actively debating if this dip is a buying opportunity, with many also focusing on the company's strategic advancements in high-voltage EV solutions as a significant long-term catalyst.

Cogent Communications Holdings, Inc. engages in the provision of Internet access and Internet Protocol (IP) communications solutions. It offers Internet access and data transport through its fiber optic, IP data-only network, ethernet transport, and colocation services. The company was founded by David Schaeffer in August 1999 and is headquartered in Washington, DC.

Cogent Communications Holdings Inc

Cogent Communications is trending after a substantial dividend cut and widespread community frustration regarding management's communication on its highly leveraged balance sheet, exacerbated by recent CEO share sales; however, some investors are eyeing a potential turnaround driven by growth in AI wavelength revenue and anticipated data center asset divestitures.

Vishay Precision Group, Inc. engages in the provision of precision measurement and sensing technologies. The firm serves a diverse array of industries and markets, including industrial, test and measurement, transportation, steel, medical, agriculture, avionics, military and space, and consumer. It operates through the following segments: Sensors, Weighing Solutions, Measurement Systems, and Corporate and Other. The Sensors segment is composed of the foil resistor and strain gage operating divisions. The Weighing Solutions segment consists of specialized modules and systems used to precisely measure weight, force torque, and pressure. The Measurement Systems segment includes specialized systems for steel production, materials development, and safety testing. The company was founded on August 28, 2009 and is headquartered in Malvern, PA.

Vishay Precision Group Inc

Vishay Precision Group (VPG) is trending following its Q4 earnings, which showcased exceptional growth in its humanoid and strategic initiatives segment, amplifying community speculation about its critical role as a precision sensor supplier for advanced humanoid robots like Tesla's Optimus and Figure AI.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

BYTE CRYPTO is gaining traction with its new listing on MEXC Meme+, energizing its dedicated "Grok's AI dog" community who are actively discussing its strong fundamentals and unique origin story as a leading AI meme coin.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN) crypto is trending due to pervasive community skepticism and accusations of it being a scam, drawing direct parallels to the controversial Mullen Automotive stock's history of significant investor losses and numerous reverse splits. While a small segment anticipates a 'run,' the dominant discussion focuses on warnings against this new token, citing the stock's past as a 'rug pull.'

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

BITI is trending as community discussions intensely link Bitcoin to the "Epstein files," with many alleging the cryptocurrency was bankrolled for illicit activities and expressing strong conviction that the "pedo-currency" is a scam destined for zero. This widespread negative sentiment is driving significant interest in BITI as an inverse investment against Bitcoin's perceived impending collapse.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kura Oncology (NASDAQ:KURA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised shares of Kura Oncology from a "sell" rating to a "hold" rating in a report on Sunday...

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline

Kura Oncology (KURA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kura Oncology (KURA) to Release Quarterly Earnings on Wednesday

Kura Oncology (NASDAQ:KURA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Kura Oncology (NASDAQ:KURA) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen cut shares of Kura Oncology from a "hold" rating to a "sell" rating in a report on Saturday...

Nan Fung Trinity HK Ltd. Invests $2.04 Million in Kura Oncology, Inc. $KURA

Nan Fung Trinity HK Ltd. acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange...

Brian Powl Sells 6,414 Shares of Kura Oncology (NASDAQ:KURA) Stock

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Brian Powl sold 6,414 shares of Kura Oncology stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of...

Sector Gamma AS Takes $3.88 Million Position in Kura Oncology, Inc. $KURA

Sector Gamma AS acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities...

Kura Oncology (NASDAQ:KURA) Cut to "Strong Sell" at Zacks Research

Zacks Research downgraded Kura Oncology from a "hold" rating to a "strong sell" rating in a research note on Tuesday...

New Strong Sell Stocks for January 21st

CRNT, KURA and CLSDQ have been added to the Zacks Rank #5 (Strong Sell) List on January 21, 2026.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.66	--	--	N/A
Q3 '25	-$0.73	-$0.85	-16.44%	MISSED
Q2 '25	-$0.41	-$0.75	-83.31%	MISSED
Q1 '25	-$0.60	-$0.66	-10.01%	MISSED
Q4 '24	-$0.64	-$0.22	65.39%	BEAT

KURA
Kura Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest KURA News

KURAKura Oncology Inc